Scottish Medicines Consortium Approves Use Of 'Nexplanon'(R) (Etonogestrel Implant 68mg) As A Long-Acting Contraceptive Implant
Main Category: Women's Health / GynecologyAlso Included In: Regulatory Affairs / Drug Approvals; Fertility
Article Date: 14 Dec 2010 - 1:00 PDT
'Scottish Medicines Consortium Approves Use Of 'Nexplanon'(R) (Etonogestrel Implant 68mg) As A Long-Acting Contraceptive Implant'
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
'Nexplanon' ® (etonogestrel implant 68mg) has been accepted by the Scottish Medicines Consortium (SMC) for use in NHS Scotland as a long acting reversible contraceptive (LARC). 1
The subdermal implant is inserted just under the skin of a woman's upper arm. 2 It contains 68mg of etonogestrel, 2 a synthetic form of the naturally occurring female sex hormone, progestogen, and also 15mg of barium sulphate, 2 which enables localisation of the implant by X-ray and CT scan. 2
Around half of UK pregnancies are unplanned 3 despite almost three-quarters of women under the age of 50 using some form of contraception. 4 Launched in 2009 by NHS Scotland, the 'Giving You More Choice' campaign was focused on increasing the awareness of LARCs, particularly the most effective LARCs such as the implant.5 Although LARCs are already used by 1 in 25 women in Scotland, NHS Scotland has engaged with patients to increase awareness and uptake.6
Notes
For full prescribing information, please refer to the Nexplanon® Summary of Product Characteristics (SPC).
SMC Advice1
ADVICE: following an abbreviated submission
etonogestrel implant 68mg (Nexplanon®) is accepted for use within NHS Scotland.
Indication under review: contraception.
In patients for whom a long-acting etonogestrel implant is an appropriate choice of contraception.
This formulation of etonogestrel implant is X-ray opaque, allowing verification of presence and location of implant.
To view the full SMC recommendation, please go here.
References
1. Scottish Medicines Consortium (SMC). Etonogestrel implant 68mg (Nexplanon®). 13 December 2010. Available here.
2. Nexplanon SPC. Available here. [Last accessed 29 November 2010]
3. Kishen M et al. Contraception in crisis. J Family Plan Reprod Health Care. 2006;32(4):211- 212
4. Ladar D. NOS. Contraception and Sexual Health omnibus survey. 2007/08. Available here. [Last accessed: 30 November 2010]
5. NHS Health Scotland. Giving you more choice campaign. Available here. [Last accessed: 02 December 2010]
6. It's here! Contraception that lasts for years. NHS Health Scotland. 2009/10. Available here. [Last accessed: 01 December 2010]
Source:
MSD
Visit our women's health / gynecology section for the latest news on this subject.
MLA
25 May. 2012. <http://www.medicalnewstoday.com/releases/211284.php>
APA
http://www.medicalnewstoday.com/releases/211284.php.
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
'Scottish Medicines Consortium Approves Use Of 'Nexplanon'(R) (Etonogestrel Implant 68mg) As A Long-Acting Contraceptive Implant'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



